Forecast earnings growth of 17% a year but down 12%, is now the time for me to buy this heavyweight FTSE stock?
This FTSE medical technology stock has strong earnings growth projections, posted impressive 2024 results, and looks very undervalued to me.
Investor's Business Daily on MSN11h
China Stocks Are Hot: These Five Are Near Buy Points
China stocks have shrugged off Trump tariff fears, buoyed by stimulus hopes, and are outperforming U.S. markets. A large ...